Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

Neuroendocrine tumors (NETs) are a heterogeneous class of diseases characterized by challenging management. Preclinical evidence shows that the PI3K/AKT/mTOR signaling pathway plays a central role in the pathogenesis and progression of NETs. Everolimus is a direct inhibitor of this pathway, and ther...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ther Adv Med Oncol
Main Authors: Pusceddu, Sara, Verzoni, Elena, Prinzi, Natialie, Mennitto, Alessia, Femia, Daniela, Grassi, Paolo, Concas, Laura, Vernieri, Claudio, Lo Russo, Giuseppe, Procopio, Giuseppe
格式: Artigo
語言:Inglês
出版: SAGE Publications 2017
主題:
Reviews
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349426/
https://ncbi.nlm.nih.gov/pubmed/28344663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016683905
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍